Abstract
All neoplasms require angiogenesis and resulting neovascularity for growth beyond 1 mm2. Quantitative microvessel density (MVD) has been shown to provide staging and prognostic significance in human prostate cancer (CaP). recently, it has been demonstrated that loss of the wild-type allele of the p53 tumour suppressor gene results in reduced expression of thrombospondin-1 (TSP-1), a potent inhibitor of angiogenesis. There is also an increased expression of vascular endothelial growth factor which promotes neovascularization. p53 gene mutation and MVD were investigated in men with prostate cancer. Sections from 103 radical prostatectomy cases were evaluated with immunohistochemistry to detect mutant p53 proteins. Quantitative MVD was performed on the cases exhibiting p53 positive staining and compared with negative fields of similar Gleason grade on the same histologic sections. Twenty of the 103 cases (19.4%) revealed positive p53 staining nuclei. In 19 of these 20 cases, the MVD in p53 positive areas was greater than corresponding control regions (overall P<0.0001). Extent of p53 abnormality, as well as MVD, correlated with pathologic stage. These data suggest that mutations of the p53 tumour suppressor gene may be associated with increased angiogenesis in CaP. In addition to providing staging and prognostic information, this relationship potentially has therapeutic implications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yu, E., Yu, E., Meyer, G. et al. The relation of p53 protein nuclear accumulation and angiogenesis in human prostatic carcinoma. Prostate Cancer Prostatic Dis 1, 39–44 (1997). https://doi.org/10.1038/sj.pcan.4500205
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500205
Keywords
This article is cited by
-
Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice
Cancer Gene Therapy (2012)
-
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
Journal of Molecular Medicine (2007)
-
Genomics of prostate cancer: Is there anything to „translate”?
Pathology & Oncology Research (2005)